About the Authors
- Emanuela Screpanti
-
Contributed equally to this work with: Emanuela Screpanti, Stefano Santaguida
Affiliation Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Milan, Italy
- Stefano Santaguida
-
Contributed equally to this work with: Emanuela Screpanti, Stefano Santaguida
Affiliation Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Milan, Italy
- Tam Nguyen
-
Affiliation Information Technology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland, United States of America
- Romano Silvestri
-
Affiliation Department of Medicinal Chemistry and Technologies, University of Rome “La Sapienza”, Rome, Italy
- Rick Gussio
-
Affiliation Information Technology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland, United States of America
- Andrea Musacchio
-
Affiliation Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Milan, Italy
- Ernest Hamel
-
Affiliation Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute at Frederick, National Institutes of Health, Frederick, Maryland, United States of America
- Peter De Wulf
-
* E-mail: peter.dewulf@ifom-ieo-campus.it
Affiliation Department of Experimental Oncology, European Institute of Oncology, IFOM-IEO Campus, Milan, Italy
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: ES SS TLN RG AM EH PDW. Performed the experiments: ES SS TLN EH. Analyzed the data: ES SS TLN RG AM EH PDW. Contributed reagents/materials/analysis tools: ES RS EH PDW. Wrote the paper: EH PDW.